Edition - S Gastrointestinal And Liver Disease 12th
12th edition Sleisenger and Fordtran's Gastrointestinal and Liver Disease , published by
- 24A: Hepatitis B (new: RNAi therapies – JNJ-3989, bepirovirsen)
- 24B: Hepatitis C (updated: pangenotypic DAA retreatment strategies)
- 24C: Hepatitis E (new: solid organ transplant considerations)
What’s New in the 12th Edition? A Thorough Update
The text is integrated with an online companion site (access code included with purchase) featuring: s gastrointestinal and liver disease 12th edition
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease has been thoroughly revised and updated to reflect the latest advances in the field. Some of the key features of this edition include: 24A: Hepatitis B (new: RNAi therapies – JNJ-3989,
A Comprehensive Resource for Gastroenterology and Hepatology
For the Hepatologist and Transplant Physician
Recommended citation:
Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease . 12th ed. Elsevier; 2020. What’s New in the 12th Edition
Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 12th Edition
The release of , marks a pivotal moment for gastroenterologists, hepatologists, and internal medicine specialists worldwide. For over fifty years, this text has served as the "gold standard" or the "bible" of digestive health.